Back to Search
WILLIAM DROBYSKI, MD
MD
Hematology & Oncology Physician
NPI: 1861443848IndividualAccepts Medicare
Specialties, Licenses & Credentials
Hematology & Oncology PhysicianPrimary
Internal Medicine — Hematology & Oncology
Code: 207RH0003X
29248(WI)
Education
UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY
Class of 1983
Research & Publications (20)
Severe autologous GVHD after hematopoietic progenitor cell transplantation for multiple myeloma.
PMID 18762759·Bone Marrow Transplant·2009
5-case
The role of allogeneic transplantation in high-risk acute myelogenous leukemia.
PMID 15452588·Leukemia·2004
6-review
Elimination of leukemia in the absence of lethal graft-versus-host disease after allogenic bone marrow transplantation.
PMID 12626559·J Immunol·2003
7-preclinical
Regulation of alloresponses after bone marrow transplantation using donor T cells expressing a thymidine kinase suicide gene.
PMID 12481900·Leuk Lymphoma·2002
7-preclinical
Role of the passive apoptotic pathway in graft-versus-host disease.
PMID 12133993·J Immunol·2002
7-preclinical
Superior survival associated with transplantation of matched unrelated versus one-antigen-mismatched unrelated or highly human leukocyte antigen-disparate haploidentical family donor marrow grafts for the treatment of hematologic malignancies: establishing a treatment algorithm for recipients of alternative donor grafts.
PMID 11806980·Blood·2002
4-observational
Protection from lethal murine graft-versus-host disease without compromise of alloengraftment using transgenic donor T cells expressing a thymidine kinase suicide gene.
PMID 11290616·Blood·2001
7-preclinical
Adoptively transferred gamma delta T cells indirectly regulate murine graft-versus-host reactivity following donor leukocyte infusion therapy in mice.
PMID 10903774·J Immunol·2000
7-preclinical
Evolving strategies to address adverse transplant outcomes associated with T cell depletion.
PMID 10894354·J Hematother Stem Cell Res·2000
6-review
Blockade of interleukin-6 signaling augments regulatory T-cell reconstitution and attenuates the severity of graft-versus-host disease.
PMID 19491393·Blood·2009
7-preclinical
Interleukin-23 secretion by donor antigen-presenting cells is critical for organ-specific pathology in graft-versus-host disease.
PMID 19059877·Blood·2009
7-preclinical
Donor leukocyte infusions to treat hematologic malignancy relapse following allo-SCT in a pediatric population.
PMID 18490913·Bone Marrow Transplant·2008
8-other
Captopril to mitigate chronic renal failure after hematopoietic stem cell transplantation: a randomized controlled trial.
PMID 18029109·Int J Radiat Oncol Biol Phys·2008
2-rct
Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.
PMID 17693581·Blood·2007
7-preclinical
Significant increase in end-stage renal disease after hematopoietic stem cell transplantation.
PMID 17351643·Bone Marrow Transplant·2007
4-observational
Homeostatic expansion and repertoire regeneration of donor T cells during graft versus host disease is constrained by the host environment.
PMID 17347406·Blood·2007
7-preclinical
Gammadelta T cells do not require fully functional cytotoxic pathways or the ability to recognize recipient alloantigens to prevent graft rejection.
PMID 17085305·Biol Blood Marrow Transplant·2006
7-preclinical
NF-kappaB as a target for the prevention of graft-versus-host disease: comparative efficacy of bortezomib and PS-1145.
PMID 16174760·Blood·2006
4-observational
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 9200 W WISCONSIN AVE, BONE MARROW TRANSPLANT
MILWAUKEE, WI 53226 - Phone
- (414) 805-6817
Quick Facts
- NPI
- 1861443848
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 1
- Years in Practice
- 43
- Publications
- 20
Are you this provider?
Claim Your Profile